The Trump administration may impose new 100% duties on some medicine. This was reported by the Financial Times, which cites sources accustomed to the matter, in response to whom the brand new tariffs can be utilized to firms that haven’t entered into agreements with the White House.
According to the British newspaper, the selection to impose new duties can be accompanied by the request made to pharmaceutical firms to extend manufacturing within the United States. The Financial Times remembers that final autumn the US president had threatened to impose 100% tariffs on imports of branded or patented medicine, except the producer had constructed a manufacturing unit within the United States.
Among the businesses which have made an settlement with the White House to extend their investments within the USA in change for a suspension of tariffs there are Pfizer, AstraZeneca e Novo Nordisk.
https://www.ilsole24ore.com/art/farmaci-amministrazione-trump-valuta-nuovi-dazi-100percento-AIqoB8IC